Cassio Murilo Hidalgo Filho
Overview
Explore the profile of Cassio Murilo Hidalgo Filho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
1
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rakaee M, Tafavvoghi M, Ricciuti B, Alessi J, Cortellini A, Citarella F, et al.
JAMA Oncol
. 2024 Dec;
11(2):109-118.
PMID: 39724105
Importance: Only a small fraction of patients with advanced non-small cell lung cancer (NSCLC) respond to immune checkpoint inhibitor (ICI) treatment. For optimal personalized NSCLC care, it is imperative to...
2.
Gouveia M, Andrade H, Hidalgo Filho C, de Melo M, Claro M, Modesto A, et al.
J Acquir Immune Defic Syndr
. 2024 Nov;
98(2):e4-e6.
PMID: 39497247
No abstract available.
3.
Ricciuti B, Elkrief A, Lin J, Zhang J, Alessi J, Lamberti G, et al.
JTO Clin Res Rep
. 2024 Oct;
5(9):100675.
PMID: 39399157
Introduction: Responses to first-line programmed cell death protein 1 inhibition vary among patients with metastatic NSCLC and a programmed death-ligand 1 (PD-L1) tumor proportion score (TPS) greater than or equal...
4.
Hidalgo Filho C, Lazar Neto F, Sobottka V, da Rocha J, Stangler L, Andrade H, et al.
JCO Glob Oncol
. 2024 Jul;
10:e2400063.
PMID: 38991187
Purpose: Most patients with cancer will be hospitalized throughout the disease course. However, most evidence on the causes and outcomes of these hospitalizations comes from administrative data or small retrospective...
5.
Polho G, Cunha M, Coelho M, Almeida-Silva J, Hidalgo Filho C, Xavier E, et al.
Clin Genitourin Cancer
. 2024 Apr;
22(3):102083.
PMID: 38658209
Background: High-dose chemotherapy followed by stem cell transplant (HDCT) is potentially curative for patients with refractory germ cell tumors (rGCT). There is scarce real-world data supporting its implementation in low-...
6.
Gouveia M, Hidalgo Filho C, Moreno R, Alves H, Ayres A, Testa L, et al.
Ecancermedicalscience
. 2024 Feb;
17:1638.
PMID: 38414937
Purpose: Central nervous system (CNS) metastases are a significant burden in breast cancer (BC). Capecitabine is a frequent choice in this scenario, but data supporting its single-agent activity are scarce....